Sept 30 (Reuters) – Liquidia shares plunged nearly 50% on Wednesday after a federal judge ruled that its lung drug infringes key patent held by rival United Therapeutics , dealing a major blow to the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Sept 30 (Reuters) - Micron Technology forecast quarterly revenue above estimates on Wednesday, signaling it expects…
Sept 30 (Reuters) - A US judge entered an order on Wednesday that allows Paramount…
(Adds detail in paragraphs 3-8) Sept 30 (Reuters) - A US judge entered an order…
VIDEO SHOWS: PRESS CONFERENCE OF GERMAN NATIONAL FOOTBALL COACH JURGEN KLOPP AND GOAL KEEPER JONAS…
By Gram Slattery and Steve Holland WASHINGTON, Sept 30 (Reuters) - US President Donald Trump…
By Kenrick Cai SAN FRANCISCO, Sept 30 (Reuters) - Alphabet's Google on Wednesday announced a…